Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

A blood pressure drug, diltiazem, may also help treat influenza.

Ziziphus jujuba Mills may have health benefits, but more research is needed to confirm its safety and effectiveness.

Natural products can help overcome cancer drug resistance.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Sex hormones affect hair and feather growth and may help manage alopecia and hormone-dependent cancers.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Plant-based ingredients in hair care are being replaced by synthetic alternatives.

Mouse zigzag hair bends form due to a 3-day cycle of changes in hair progenitors and their environment.

ELL is crucial for gene transcription related to skin cell growth.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Printing human stem cells and a special matrix during surgery can help grow new skin and hair-like structures in rats.

Autologous cell-based therapies, especially SVF, effectively and safely improve atrophic acne scars.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

The workshop promoted better medicine use and health practices through global collaboration.

The workshop successfully promoted better medicine use and international collaboration.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

New genetic variants linked to albinism were found in Pakistani families.